• Experimental Antibody Drug Neutralizes COVID-19 Variants

    4 days ago - By Medscape

    An experimental monoclonal antibody treatment for COVID-19 being developed by Eli Lilly and AbCellera Biologics can 'potently' neutralize numerous coronavirus variants, scientists have found in test tube experiments.
    Reuters Health Information
    Read more ...

     

  • COVID-19 Antibodies Still Detectable at 12 Months

    4 days ago - By Medscape

    Some COVID-19 survivors infected early in the pandemic still have detectable antibodies against the virus a year later, according to a new study.
    Reuters Health Information
    Read more ...

     

  • No Link Seen Between COVID-19 and Aspirin or Ibuprofen

    4 days ago - By Medscape

    A large new study found no indication that use of NSAIDs like aspirin or ibuprofen increases people's vulnerability to infection by the new coronavirus.
    Reuters Health Information
    Read more ...

     

  • Canada's High-Risk Populations Face COVID-19 Vaccine Barriers

    4 days ago - By Medscape

    As Canada's vaccination campaign ramps up, people at higher risk of transmitting COVID-19 often lack the resources to navigate labyrinthine booking systems or the documentation that would ease their path to inoculation.
    Reuters Health Information
    Read more ...

     

  • COVID-19 Delays Treatment of Other Ailments

    COVID-19 Delays Treatment of Other Ailments

    4 days ago - By Medindia Health

    A new survey has found that high concern for COVID-19 infections resulted in delay in treatment of people with non-COVID ailments.
    Read more ...